Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-08-16
2011-08-16
Gambel, Phillip (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C530S387300, C530S388100, C530S388200, C424S130100, C424S133100, C424S141100, C424S145100, C424S158100
Reexamination Certificate
active
07999082
ABSTRACT:
Disclosed are novel inhibitors of the alternative complement pathway and particularly, novel anti-factor B antibodies. Also disclosed is the use of such inhibitors to reduce or prevent airway hyperresponsiveness and/or airway inflammation by selectively inhibiting the alternative complement pathway, thereby treating diseases in which such conditions play a role. Also disclosed is the use of such inhibitors to reduce or prevent other diseases and conditions, including ischemia-reperfusion injury, by inhibition of the alternative complement pathway.
REFERENCES:
patent: 4883784 (1989-11-01), Kaneko
patent: 5679546 (1997-10-01), Ko et al.
patent: 5869615 (1999-02-01), Hourcade et al.
patent: 5976540 (1999-11-01), Rittershaus et al.
patent: 6165463 (2000-12-01), Platz et al.
patent: 6248365 (2001-06-01), Römisch et al.
patent: 6458360 (2002-10-01), Fearon et al.
patent: 6521450 (2003-02-01), Atkinson et al.
patent: 6820011 (2004-01-01), Chen et al.
patent: 6897290 (2005-05-01), Atkinson et al.
patent: 2002/0015701 (2002-02-01), Gupta-Bansal et al.
patent: 2002/0081293 (2002-06-01), Fung et al.
patent: 2003/0198636 (2003-10-01), Gupta-Bansal et al.
patent: 2003/0235582 (2003-12-01), Singh et al.
patent: 2005/0107319 (2005-05-01), Bansal et al.
patent: 2005/0169915 (2005-08-01), Do Couto et al.
patent: 2005/0255552 (2005-11-01), Flynn et al.
patent: 2006/0002944 (2006-01-01), Ashkenazi et al.
patent: 2006/0134098 (2006-06-01), Bebbington et al.
patent: 2006/0178308 (2006-08-01), Schwaeble et al.
patent: 2006/0263819 (2006-11-01), Hageman et al.
patent: 2006/0292141 (2006-12-01), Holers et al.
patent: 2007/0020647 (2007-01-01), Hageman et al.
patent: 2007/0065433 (2007-03-01), Mollnes et al.
patent: 2007/0183970 (2007-08-01), Goldenberg et al.
patent: 2008/0267980 (2008-10-01), Tomlinson et al.
patent: 2008/0299114 (2008-12-01), Emlen et al.
patent: 2009/0175847 (2009-07-01), Barghorn et al.
patent: WO 99/42133 (1999-08-01), None
patent: WO 00/21559 (2000-04-01), None
patent: WO 01/47963 (2001-07-01), None
patent: WO 2004/022096 (2004-03-01), None
patent: WO 2004/103288 (2004-12-01), None
patent: WO-2004/106369 (2004-12-01), None
patent: WO-2004/106369 (2004-12-01), None
patent: WO-2005/069970 (2005-08-01), None
patent: WO-2006/012621 (2006-02-01), None
patent: WO-2006/012621 (2006-02-01), None
patent: WO-2006/062716 (2006-06-01), None
patent: WO-2006/062716 (2006-06-01), None
patent: WO-2006/083533 (2006-08-01), None
patent: WO-2006/083533 (2006-08-01), None
patent: WO-2007/011363 (2007-01-01), None
patent: WO-2007/011363 (2007-01-01), None
patent: WO-2007/029008 (2007-03-01), None
patent: WO-2007/029008 (2007-03-01), None
patent: WO-2007/032876 (2007-03-01), None
patent: WO-2007/032876 (2007-03-01), None
patent: WO-2007/056227 (2007-05-01), None
patent: WO-2007/056227 (2007-05-01), None
patent: WO-2008/140653 (2008-11-01), None
patent: WO-2008/140653 (2008-11-01), None
Bost et al., Immunological Investigation 17: 577-586, 1988.
Bendayan, J. Histochem. Cytochem. 43: 881-886, 1995.
Lederman et al., Molecular Immunology 28: 1171-1181, 1991.
Li et al., PNAS 77: 3211-3214, 1980.
Thurman et al.,Molecular Immunology(2005) 42:87-97.
Glovsky et al.,Annals of Allergy, Asthma, and Immunology(2004), 93:6, pp. 513-523 & 605.
Girardi et al.,J. Clinical Investigation(2003) 112:11, pp. 1644-1654.
Thurman et al., “A Novel Inhibitor of the Alternative Pathway of Complement Protects Mice from Ischemic Acute Renal Failure”, Abst. Oct. 2004, American Nephrology Society Meeting, 1 page.
Thurman et al., Abst. #254,Molecular Immunology41 (2004), 1 page.
Thurman et al., Abst. #256,Molecular Immunology41 (2004), p. 319.
Girardi, G. et al. (Feb. 2004). “Complement C5a Receptors and Neutrophils Mediate Fetal Injury in the Antiphospholipid Syndrome,”J. Clin. Invest.corrigendum 113(4):646.
Clardy et al., (1992), “In vitro inhibition of complement activation using a monoclonal antibody (MoAb) directed against human factor B (FB)”, Pediatric Res. 31:331A (meeting abstract).
Clardy et al., (1994), “Complement activation by whole endotoxin is blocked by a monoclonal antibody to factor B,” Infect. Immunity 62(1):4549-55.
Kolb et al., (1989), “Ba and Bb fragments of factor B activation: fragment production, biological activities, neoepitope expression and quantitation in clinical samples,” Complement & Inflammation 6:175-204.
Tanaka et al., (1991), “Murine monoclonal anti-Ba antibody that enhances haemolytic activity of factor B,” Immunol. 73:383-87.
International Search Report for International (PCT) Patent Application No. PCT/US2005/004346, mailed Jul. 7, 2005.
Written Opinion for International (PCT) Patent Application No. PCT/US2005/004346, mailed Jul. 7, 2005.
International Preliminary Report on Patentability for International (PCT) Patent Application No. PCT/US2005/004346, issued Aug. 14, 2006.
Holers, V.M. et al. (2004). “The Alternative Pathway of Complement in Disease: Opportunities for Therapeutic Targeting,”Molecular Immunology41:147-152.
Hourcade, D.E. et al. (1995). “Analysis of the Short Consensus Repeats of Human Complement Factor B by Site-directed Mutagenesis,”J. Bio. Chem.270(34):19716-19722.
Supplementary Partial European Search Report mailed on Jul. 7, 2008, for EP Application No. 05722948, filed on Feb. 10, 2005, 7 pages.
Thurman, J.M. et al. (2003). “Lack of a Functional Alternative Complement Pathway Ameliorates Ischemic Acute Renal Failure in Mice,”J. Immunology170(3):1517-1523.
Ueda, A. et al. (Feb. 15, 1987). “Probing Functional Sites on Complement Protein B with Monoclonal Antibodies: Evidence for C3b-Binding Sites on Ba,”J. Immunology138(4):1143-1149.
Anonymous. (Date Unknown). “Monoclonal Antibody to Human Factor B (Ba), Catalog No. A225” inQuidel Corporation Product Catalog, located at ://www.quidel.com/products/product—detail.php?prod=82&group=2>, last visited on Aug. 4, 2008, two pages.
Anonymous. (Date Unknown). “Monoclonal Antibody to Human Factor B (Bb), Catalog No. A227,” inQuidel Corporation Product Catalog, located at ://www.quidel.com/products/product—detail.php?group=2&prod=83>, last visited on Aug. 4, 2008, two pages.
Chardès, T. et al. (1999). “Efficient Amplification and Direct Sequencing of Mouse Variable Regions from any Immunoglobulin Gene Family,”FEBS Lett. 452(3):386-394.
Choi, W.S. et al. (Sep. 25, 2001). “Inhalation Delivery of Proteins from Ethanol Suspensions,”Proc. Natl. Acad. Sci. 98(20):11103-11107.
International Preliminary Report on Patentability mailed on Sep. 24, 2009, for PCT Application No. PCT/US2008/003381, filed on Mar. 14, 2008, 9 pages.
International Search Report mailed on Feb. 11, 2009, for PCT Application No. PCT/US2008/003381, filed on Mar. 14, 2008, 6 pages.
Stribling, R. et al. (Dec. 1992). “Aerosol Gene Deliveryin Vivo,”Proc. Natl. Acad. Sci. USA89:11277-11281.
Tatusova, T.A. et al. (May 15, 1999). “BLAST 2 Sequences, a New Tool For Comparing Protein and Nucleotide Sequences”,FEMS Microbiol. Lett. 174(2):247-250.
Taube, C. et al. (May 23, 2006). “Factor B of the Alternative Complement Pathway Regulates Development of Airway Hyperresponsiveness and Inflammation,”Proc. Natl. Acad. Sci. USA103(21):8084-8089.
Written Opinion of the International Searching Authority mailed on Feb. 11, 2009, for PCT Application No. PCT/US2008/003381, filed on Mar. 14, 2008, 7 pages.
Abass, A.K. et al. eds. (1991).Cellular and Molecular Immunology, W.B. Saunders Company: Philadelphia, PA, pp. 54.
Alexander, J.J. et al. (2005). “Complement-Dependent Apoptosis and Inflammatory Gene Changes in Murine Lupus Cerebritis,”J. Immunol.175:8312-8319.
Attwood, T.K. (Oct. 20, 2000). “The Babel of Bioinformatics,”Science290:471-473.
Bendig, M.M. (1995). “Humanization of Rodent Monoclonal Antibodies by CDR Grafting,”METHODS: A Companion to Methods in Enzym
Gelfand Erwin W.
Gilkeson Gary Steven
Holers Vernon Michael
Taube Christian
Thurman Joshua M.
Gambel Phillip
Morrison & Foerster / LLP
MUSC Foundation for Research Development
National Jewish Medical and Research Center
The Regents of the University of Coloraodo
LandOfFree
Anti-factor B antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-factor B antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-factor B antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2759927